“Billionaire Sam Zell is among a group of savvy investors backing a small North Carolina biotechnology engineering company that has developed what it believes is a breakthrough product: a disinfectant that kills bacteria on surfaces and creates a barrier to additional contamination for up to 90 days.”
Read Forbes Mergermarket’s profile of Novalent and how our game-changing research and patents have attracted attention from investors around the globe.
Novalent® is a leading US biotechnology engineering firm which has pioneered the development of long-lasting technology to protect against bacteria. Novalent® technology is based on a patented, non-toxic monomolecular layer that continuously inhibits microbial growth for up to 90 days on surfaces after application. Novalent is privately backed and is headquartered in Greensboro, North Carolina. For more information on Novalent®, visit www.novalent.com.